Oncoclinicas updates financial calendar for upcoming disclosures
Reuters2026/08/07 21:06- Oncoclinicas scheduled full-year 2025 annual financial statements, including DFP, for April 9, 2026.
- Results presentation for the full year set for April 10, 2026.
- Annual general meeting slated for April 30, 2026; management proposal, notice of call due March 31, 2026.
- 1Q ITR due May 14, 2026; results presentation set for May 15, 2026.
- Reference Form filing scheduled for May 29, 2026; Brazilian Corporate Governance Code report due July 31, 2026.
- 2Q ITR due Aug. 14, 2026; results presentation set for Aug. 17, 2026.
- 3Q ITR due Nov. 11, 2026; results presentation set for Nov. 12, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Fogo Foundation Attacked, Approximately 400 Million FOGO Tokens Transferred
Crypto prices
More
